首页 > 最新文献

The Lancet Regional Health: Western Pacific最新文献

英文 中文
Comprehensive systematic review and meta-analysis of risk factors for childhood obesity in China and future intervention strategies
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-23 DOI: 10.1016/j.lanwpc.2025.101553
Yanfen Jiang , Jiajin Hu , Fengyan Chen , Borui Liu , Mengna Wei , Wenqi Xia , Yinkun Yan , Jinchen Xie , Shufa Du , Xiangyang Tian , Izzuddin M. Aris , Youfa Wang , Jianduan Zhang

Background

Childhood obesity is a critical public health concern in China. This study identified the key determinants of childhood obesity in China and provided recommendations for future intervention strategies.

Methods

We conducted a comprehensive systematic review and meta-analysis to identify multiple-level determinants of childhood obesity in China and calculated the population-attributable risk percentage (PAR%) for each modifiable determinant. We also conducted expert consultations using the Socio-ecological Model to gain insights into the causes of obesity. Additionally, we reviewed current Chinese policies on childhood obesity intervention and compared them with the priorities identified in the meta-analysis and expert consultation to pinpoint policy gaps.

Findings

Our meta-analysis, incorporating 419 studies, identified 33 risk factors for childhood obesity. At the individual-level, we identified 11 key contributors including early-life risk factors such as maternal pre-pregnancy overweight/obesity (PAR%: 16.7%), breastfeeding duration of less than six months (14.1%), cesarean section delivery (11.1%), excessive gestational weight gain (10.5%), high birth weight (4.2%), and gestational diabetes mellitus (3.6%), and 13 behavioral factors during childhood such as sugar sweetened beverage consumption (16.4%), insufficient sleep (15.0%), rapid eating speed (14.7%), less than 2 h of physical activity per day (6.3%), and over 2 h of daily screen time (5.6%). We also identified six prominent family-level factors such as maternal overweight/obesity (24.3%) and paternal overweight/obesity (23.5%). Expert consultation highlighted genetic factors, and prioritized actionable risk factors, particularly dietary, expanding on the meta-analysis findings. Finally, policy review revealed that existing Chinese policies inadequately addressed these determinants, especially at the macro and structural levels.

Interpretation

This study highlights the importance of targeting high-risk populations and addressing detrimental behavioral factors, especially on early-life influences. However, real-world impacts require a comprehensive approach that goes beyond individual factors. More future effective intervention efforts are needed.

Funding

This study was funded by the National Natural Science Foundation of China (NSFC 82073567; NSFC 82273641) and the National Science and Technology Innovation 2030, Noncommunicable Chronic Diseases-National Science and Technology Major Project (Grant No. 2023ZD0508500, 2023ZD0508504).
{"title":"Comprehensive systematic review and meta-analysis of risk factors for childhood obesity in China and future intervention strategies","authors":"Yanfen Jiang ,&nbsp;Jiajin Hu ,&nbsp;Fengyan Chen ,&nbsp;Borui Liu ,&nbsp;Mengna Wei ,&nbsp;Wenqi Xia ,&nbsp;Yinkun Yan ,&nbsp;Jinchen Xie ,&nbsp;Shufa Du ,&nbsp;Xiangyang Tian ,&nbsp;Izzuddin M. Aris ,&nbsp;Youfa Wang ,&nbsp;Jianduan Zhang","doi":"10.1016/j.lanwpc.2025.101553","DOIUrl":"10.1016/j.lanwpc.2025.101553","url":null,"abstract":"<div><h3>Background</h3><div>Childhood obesity is a critical public health concern in China. This study identified the key determinants of childhood obesity in China and provided recommendations for future intervention strategies.</div></div><div><h3>Methods</h3><div>We conducted a comprehensive systematic review and meta-analysis to identify multiple-level determinants of childhood obesity in China and calculated the population-attributable risk percentage (PAR%) for each modifiable determinant. We also conducted expert consultations using the Socio-ecological Model to gain insights into the causes of obesity. Additionally, we reviewed current Chinese policies on childhood obesity intervention and compared them with the priorities identified in the meta-analysis and expert consultation to pinpoint policy gaps.</div></div><div><h3>Findings</h3><div>Our meta-analysis, incorporating 419 studies, identified 33 risk factors for childhood obesity. At the individual-level, we identified 11 key contributors including early-life risk factors such as maternal pre-pregnancy overweight/obesity (PAR%: 16.7%), breastfeeding duration of less than six months (14.1%), cesarean section delivery (11.1%), excessive gestational weight gain (10.5%), high birth weight (4.2%), and gestational diabetes mellitus (3.6%), and 13 behavioral factors during childhood such as sugar sweetened beverage consumption (16.4%), insufficient sleep (15.0%), rapid eating speed (14.7%), less than 2 h of physical activity per day (6.3%), and over 2 h of daily screen time (5.6%). We also identified six prominent family-level factors such as maternal overweight/obesity (24.3%) and paternal overweight/obesity (23.5%). Expert consultation highlighted genetic factors, and prioritized actionable risk factors, particularly dietary, expanding on the meta-analysis findings. Finally, policy review revealed that existing Chinese policies inadequately addressed these determinants, especially at the macro and structural levels.</div></div><div><h3>Interpretation</h3><div>This study highlights the importance of targeting high-risk populations and addressing detrimental behavioral factors, especially on early-life influences. However, real-world impacts require a comprehensive approach that goes beyond individual factors. More future effective intervention efforts are needed.</div></div><div><h3>Funding</h3><div>This study was funded by the <span>National Natural Science Foundation of China</span> (NSFC <span><span>82073567</span></span>; NSFC <span><span>82273641</span></span>) and the <span>National Science and Technology Innovation</span> 2030, <span>Noncommunicable Chronic Diseases-National Science and Technology Major Project</span> (Grant No. <span><span>2023ZD0508500</span></span>, <span><span>2023ZD0508504</span></span>).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"58 ","pages":"Article 101553"},"PeriodicalIF":7.6,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143864084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secular trends in physical fitness and cardiovascular risks among Chinese college students: an analysis of five successive national surveys between 2000 and 2019
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-23 DOI: 10.1016/j.lanwpc.2025.101560
Shan Cai , Yihang Zhang , Ziyue Chen , Yunfei Liu , Jiajia Dang , Jiaxin Li , Tianyu Huang , Ziyue Sun , Yanhui Dong , Jun Ma , Yi Song

Background

With increasing concerns about early-onset cardiovascular diseases, it is essential to understand the distribution of cardiovascular health among young adults. This study aimed to characterize trends in physical fitness and the prevalence of overweight/obesity (OWOB), elevated blood pressure (EBP), and their comorbidity among Chinese college students from 2000 to 2019 and to analyze the changes in their associations and subgroup differences.

Methods

Data were extracted from five cycles of the Chinese National Survey on Students' Constitution and Health (2000–2019), including 241,710 college students aged 19–22. Physical fitness indicator (PFI) was computed using standardized z-scores of forced vital capacity, sit-and-reach, 50-m dash, standing long jump, muscle strength, and endurance running. OWOB was defined as a body mass index ≥25 kg/m2, and EBP as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg. Comorbidity was defined as the co-occurrence of OWOB and EBP. Mixed-effects logistic regression was used to analyze associations, and generalized linear mixed-effects models were applied to examine dose-response relationships.

Findings

The median of college students' PFI deteriorated continuously from −0.16 in 2000 to −1.99 in 2019, with boys experiencing a faster decline than girls. The prevalence of OWOB, EBP, and comorbidity increased significantly from 3.7%, 2.2%, and 0.3% in 2000 to 14.0%, 5.2%, and 1.8% in 2019, respectively, with boys exhibiting higher prevalence than girls. Decreasing PFI levels were significantly associated with the increasing prevalence of OWOB, EBP, and comorbidity, and such associations were strongest in 2019. L-shaped curves were observed for the relationships between PFI and the prevalence of OWOB, EBP, and comorbidity, with stronger associations in boys. Provincial population attributable fraction showed that when improving the PFI levels from low to middle-low or above, college students in Guizhou, Sichuan, and Yunnan provinces exhibited the most reductions in OWOB, EBP, and comorbidity.

Interpretation

Physical fitness among Chinese college students has significantly declined over the past two decades, accompanied by marked increases in the burden of cardiovascular risks. There is an urgent need to increase the focus on college students’ health and establish a college-based physical examination system to assess their long-term cardiovascular function.

Funding

The present study was funded by National Key R&D Program of China (Grant No. 2024YFC2707901 to Yi Song), National Natural Science Foundation of China (Grant No. 82273654 to Yi Song), and Beijing Office for Education Sciences Planning (Grant No. BBAA22027 to Yi Song).
{"title":"Secular trends in physical fitness and cardiovascular risks among Chinese college students: an analysis of five successive national surveys between 2000 and 2019","authors":"Shan Cai ,&nbsp;Yihang Zhang ,&nbsp;Ziyue Chen ,&nbsp;Yunfei Liu ,&nbsp;Jiajia Dang ,&nbsp;Jiaxin Li ,&nbsp;Tianyu Huang ,&nbsp;Ziyue Sun ,&nbsp;Yanhui Dong ,&nbsp;Jun Ma ,&nbsp;Yi Song","doi":"10.1016/j.lanwpc.2025.101560","DOIUrl":"10.1016/j.lanwpc.2025.101560","url":null,"abstract":"<div><h3>Background</h3><div>With increasing concerns about early-onset cardiovascular diseases, it is essential to understand the distribution of cardiovascular health among young adults. This study aimed to characterize trends in physical fitness and the prevalence of overweight/obesity (OWOB), elevated blood pressure (EBP), and their comorbidity among Chinese college students from 2000 to 2019 and to analyze the changes in their associations and subgroup differences.</div></div><div><h3>Methods</h3><div>Data were extracted from five cycles of the Chinese National Survey on Students' Constitution and Health (2000–2019), including 241,710 college students aged 19–22. Physical fitness indicator (PFI) was computed using standardized z-scores of forced vital capacity, sit-and-reach, 50-m dash, standing long jump, muscle strength, and endurance running. OWOB was defined as a body mass index ≥25 kg/m<sup>2</sup>, and EBP as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg. Comorbidity was defined as the co-occurrence of OWOB and EBP. Mixed-effects logistic regression was used to analyze associations, and generalized linear mixed-effects models were applied to examine dose-response relationships.</div></div><div><h3>Findings</h3><div>The median of college students' PFI deteriorated continuously from −0.16 in 2000 to −1.99 in 2019, with boys experiencing a faster decline than girls. The prevalence of OWOB, EBP, and comorbidity increased significantly from 3.7%, 2.2%, and 0.3% in 2000 to 14.0%, 5.2%, and 1.8% in 2019, respectively, with boys exhibiting higher prevalence than girls. Decreasing PFI levels were significantly associated with the increasing prevalence of OWOB, EBP, and comorbidity, and such associations were strongest in 2019. L-shaped curves were observed for the relationships between PFI and the prevalence of OWOB, EBP, and comorbidity, with stronger associations in boys. Provincial population attributable fraction showed that when improving the PFI levels from low to middle-low or above, college students in Guizhou, Sichuan, and Yunnan provinces exhibited the most reductions in OWOB, EBP, and comorbidity.</div></div><div><h3>Interpretation</h3><div>Physical fitness among Chinese college students has significantly declined over the past two decades, accompanied by marked increases in the burden of cardiovascular risks. There is an urgent need to increase the focus on college students’ health and establish a college-based physical examination system to assess their long-term cardiovascular function.</div></div><div><h3>Funding</h3><div>The present study was funded by National Key R&amp;D Program of China (Grant No. 2024YFC2707901 to Yi Song), <span>National Natural Science Foundation of China</span> (Grant No. <span><span>82273654</span></span> to Yi Song), and <span>Beijing Office for Education Sciences Planning</span> (Grant No. <span><span>BBAA22027</span></span> to Yi Song).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"58 ","pages":"Article 101560"},"PeriodicalIF":7.6,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143864085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-23 DOI: 10.1016/j.lanwpc.2025.101554
Kehang Li , Yuchen Wei , Chi Tim Hung , Carlos King Ho Wong , Xi Xiong , Paul Kay Sheung Chan , Shi Zhao , Zihao Guo , Guozhang Lin , Qiaoge Chi , Carrie Ho Kwan Yam , Tsz Yu Chow , Conglu Li , Xiaoting Jiang , Shuk Yu Leung , Ka Li Kwok , Eng Kiong Yeoh , Ka Chun Chong

Background

As the COVID-19 pandemic shifted into the post-pandemic period in early 2023, following the COVID-19 normalization with relaxation of stringent control measures and high vaccination coverage in Hong Kong, its long-term impact on mortality remains challenging with necessary needs of data-driven insights. This study examined the pattern of post-pandemic excess mortality in Hong Kong.

Methods

We analyzed weekly inpatient death data from public hospitals from January 1, 2013, to June 1, 2024, using a mixed model with over-dispersed Poisson regression. Expected mortality was estimated as the difference between observed mortality and baseline derived from pre-pandemic data. Age-stratified analyses of overall and cause-specific mortality were conducted across the pre-Omicron pandemic, Omicron, and post-pandemic periods.

Findings

In the post-pandemic period, the excess mortality declined but remained six-fold higher (37.66 [95% CI: 32.72–42.60] per 100,000) than pre-Omicron level, maintaining significance after adjusting for age (32.79 [95% CI: 28.13–37.46] per 100,000). The older population experienced sustained excess mortality, with crude estimates of 100.51 and 586.74 per 100,000 among those aged 65–79 years and ≥80 years, respectively, primarily due to respiratory diseases. Younger population showed near-zero overall excess mortality, whereas increased excess mortality among them occurred in heart disease, cerebrovascular disease, and injuries.

Interpretation

Our findings highlight the lasting mortality impact of pandemic among vulnerable populations, specifically the older population, possibly due to the post-COVID conditions and circulating COVID-19, suggesting the need for targeted interventions for this group.

Funding

Health and Medical Research Fund.
{"title":"Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study","authors":"Kehang Li ,&nbsp;Yuchen Wei ,&nbsp;Chi Tim Hung ,&nbsp;Carlos King Ho Wong ,&nbsp;Xi Xiong ,&nbsp;Paul Kay Sheung Chan ,&nbsp;Shi Zhao ,&nbsp;Zihao Guo ,&nbsp;Guozhang Lin ,&nbsp;Qiaoge Chi ,&nbsp;Carrie Ho Kwan Yam ,&nbsp;Tsz Yu Chow ,&nbsp;Conglu Li ,&nbsp;Xiaoting Jiang ,&nbsp;Shuk Yu Leung ,&nbsp;Ka Li Kwok ,&nbsp;Eng Kiong Yeoh ,&nbsp;Ka Chun Chong","doi":"10.1016/j.lanwpc.2025.101554","DOIUrl":"10.1016/j.lanwpc.2025.101554","url":null,"abstract":"<div><h3>Background</h3><div>As the COVID-19 pandemic shifted into the post-pandemic period in early 2023, following the COVID-19 normalization with relaxation of stringent control measures and high vaccination coverage in Hong Kong, its long-term impact on mortality remains challenging with necessary needs of data-driven insights. This study examined the pattern of post-pandemic excess mortality in Hong Kong.</div></div><div><h3>Methods</h3><div>We analyzed weekly inpatient death data from public hospitals from January 1, 2013, to June 1, 2024, using a mixed model with over-dispersed Poisson regression. Expected mortality was estimated as the difference between observed mortality and baseline derived from pre-pandemic data. Age-stratified analyses of overall and cause-specific mortality were conducted across the pre-Omicron pandemic, Omicron, and post-pandemic periods.</div></div><div><h3>Findings</h3><div>In the post-pandemic period, the excess mortality declined but remained six-fold higher (37.66 [95% CI: 32.72–42.60] per 100,000) than pre-Omicron level, maintaining significance after adjusting for age (32.79 [95% CI: 28.13–37.46] per 100,000). The older population experienced sustained excess mortality, with crude estimates of 100.51 and 586.74 per 100,000 among those aged 65–79 years and ≥80 years, respectively, primarily due to respiratory diseases. Younger population showed near-zero overall excess mortality, whereas increased excess mortality among them occurred in heart disease, cerebrovascular disease, and injuries.</div></div><div><h3>Interpretation</h3><div>Our findings highlight the lasting mortality impact of pandemic among vulnerable populations, specifically the older population, possibly due to the post-COVID conditions and circulating COVID-19, suggesting the need for targeted interventions for this group.</div></div><div><h3>Funding</h3><div><span>Health and Medical Research Fund</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"58 ","pages":"Article 101554"},"PeriodicalIF":7.6,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143864083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “The prevalence and associated disability burden of mental disorders in children and adolescents in China: a systematic analysis of data from the Global Burden of Disease Study” [The Lancet Regional Health–Western Pacific Volume 55, February 2025, 101486]
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-23 DOI: 10.1016/j.lanwpc.2025.101556
Wanyue Dong , Yunning Liu , Ruhai Bai , Lei Zhang , Maigeng Zhou
{"title":"Corrigendum to “The prevalence and associated disability burden of mental disorders in children and adolescents in China: a systematic analysis of data from the Global Burden of Disease Study” [The Lancet Regional Health–Western Pacific Volume 55, February 2025, 101486]","authors":"Wanyue Dong ,&nbsp;Yunning Liu ,&nbsp;Ruhai Bai ,&nbsp;Lei Zhang ,&nbsp;Maigeng Zhou","doi":"10.1016/j.lanwpc.2025.101556","DOIUrl":"10.1016/j.lanwpc.2025.101556","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"58 ","pages":"Article 101556"},"PeriodicalIF":7.6,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143864086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying and visualising temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes: a population-based study
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-01 DOI: 10.1016/j.lanwpc.2025.101532
Hongjiang Wu , Haobin Zhou , Chuiguo Huang , Aimin Yang , Eric S.H. Lau , Xinge Zhang , Juliana N.M. Lui , Baoqi Fan , Mai Shi , Ronald C.W. Ma , Alice P.S. Kong , Elaine Chow , Wing-Yee So , Juliana C.N. Chan , Andrea O.Y. Luk

Background

People with type 2 diabetes are increasingly susceptible to complications that are not specific to diabetes. We aimed to examine the temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes.

Methods

We included 758,254 people with incident type 2 diabetes between 2002 and 2018 in Hong Kong, followed up until 2019. We included hospitalisations for 72 selected diseases and all-cause deaths. We derived the temporal trajectories of hospitalisations based on pairs of disease associations and identified trajectory clusters using Markov Cluster Algorithm.

Findings

During a median follow-up of 7.8 (IQR: 4–12) years, 57.6% of people experienced a hospitalisation for any of the 72 selected diseases and 22.6% of people died. Among the 5184 directional disease pairs, 95 were identified as having a significant and directional association. The three most common disease pairs were hospitalisations for urinary tract infection followed by pneumonia, ischemic heart disease followed by heart failure, and ischemic stroke followed by pneumonia. Cardiovascular and kidney diseases were predominant in the hospitalisation trajectories. However, these traditional complications had complex associations both among themselves and with various non-traditional complications across multiple systems. Three distinct trajectory clusters were identified, with heart failure/chronic kidney disease, pneumonia, and urinary tract infection as central diseases.

Interpretation

Cardiovascular and kidney diseases interacted with a broad set of non-traditional complications to influence the overall patterns of hospitalisation progression in people with diabetes, highlighting the need to broaden diabetes care to consider complications beyond the traditional focus.

Funding

Direct Grant for Research from The Chinese University of Hong Kong.
{"title":"Identifying and visualising temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes: a population-based study","authors":"Hongjiang Wu ,&nbsp;Haobin Zhou ,&nbsp;Chuiguo Huang ,&nbsp;Aimin Yang ,&nbsp;Eric S.H. Lau ,&nbsp;Xinge Zhang ,&nbsp;Juliana N.M. Lui ,&nbsp;Baoqi Fan ,&nbsp;Mai Shi ,&nbsp;Ronald C.W. Ma ,&nbsp;Alice P.S. Kong ,&nbsp;Elaine Chow ,&nbsp;Wing-Yee So ,&nbsp;Juliana C.N. Chan ,&nbsp;Andrea O.Y. Luk","doi":"10.1016/j.lanwpc.2025.101532","DOIUrl":"10.1016/j.lanwpc.2025.101532","url":null,"abstract":"<div><h3>Background</h3><div>People with type 2 diabetes are increasingly susceptible to complications that are not specific to diabetes. We aimed to examine the temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes.</div></div><div><h3>Methods</h3><div>We included 758,254 people with incident type 2 diabetes between 2002 and 2018 in Hong Kong, followed up until 2019. We included hospitalisations for 72 selected diseases and all-cause deaths. We derived the temporal trajectories of hospitalisations based on pairs of disease associations and identified trajectory clusters using Markov Cluster Algorithm.</div></div><div><h3>Findings</h3><div>During a median follow-up of 7.8 (IQR: 4–12) years, 57.6% of people experienced a hospitalisation for any of the 72 selected diseases and 22.6% of people died. Among the 5184 directional disease pairs, 95 were identified as having a significant and directional association. The three most common disease pairs were hospitalisations for urinary tract infection followed by pneumonia, ischemic heart disease followed by heart failure, and ischemic stroke followed by pneumonia. Cardiovascular and kidney diseases were predominant in the hospitalisation trajectories. However, these traditional complications had complex associations both among themselves and with various non-traditional complications across multiple systems. Three distinct trajectory clusters were identified, with heart failure/chronic kidney disease, pneumonia, and urinary tract infection as central diseases.</div></div><div><h3>Interpretation</h3><div>Cardiovascular and kidney diseases interacted with a broad set of non-traditional complications to influence the overall patterns of hospitalisation progression in people with diabetes, highlighting the need to broaden diabetes care to consider complications beyond the traditional focus.</div></div><div><h3>Funding</h3><div>Direct Grant for Research from <span>The Chinese University of Hong Kong</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"57 ","pages":"Article 101532"},"PeriodicalIF":7.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143737893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Universal health coverage for immigrants in Japan
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-01 DOI: 10.1016/j.lanwpc.2025.101539
Soichiro Saeki
{"title":"Universal health coverage for immigrants in Japan","authors":"Soichiro Saeki","doi":"10.1016/j.lanwpc.2025.101539","DOIUrl":"10.1016/j.lanwpc.2025.101539","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"57 ","pages":"Article 101539"},"PeriodicalIF":7.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143748583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapy in nasopharyngeal carcinoma: current status and unanswered questions
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-01 DOI: 10.1016/j.lanwpc.2025.101547
Xu Liu , Jun Ma
{"title":"Immunotherapy in nasopharyngeal carcinoma: current status and unanswered questions","authors":"Xu Liu ,&nbsp;Jun Ma","doi":"10.1016/j.lanwpc.2025.101547","DOIUrl":"10.1016/j.lanwpc.2025.101547","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"57 ","pages":"Article 101547"},"PeriodicalIF":7.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143776471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-01 DOI: 10.1016/j.lanwpc.2025.101537
Yoon-Jung Kang , Qingwei Luo , Joachim Worthington , Anna Kelly , Jeff Cuff , John Zalcberg , Karen Canfell , Julia Steinberg

Background

Targeted cancer treatment based on mismatch repair deficiency (dMMR), microsatellite instability (MSI), or high tumour mutational burden (TMB) holds promise for improving patient outcomes, but presents substantial healthcare costs.

Methods

Using validated statistical methods, we projected 1-year to 5-year prevalence of individuals diagnosed with solid tumours exhibiting these biomarkers in Australia to 2042, for all solid cancers combined and 23 individual cancer types/groups, and separately for all stages combined, advanced disease at diagnosis (here, distant metastasis/lymph node involvement), and advanced disease after progression post-diagnosis.

Findings

The 5-year prevalence of individuals diagnosed with any solid cancer regardless of biomarker status is estimated to increase by 54·2%, from 438,346 in 2018 to 675,722 in 2042 (advanced disease at diagnosis: by 37·6% from 109,855 to 151,199), primarily due to population growth and ageing. The 5-year prevalence of individuals whose tumours exhibit a biomarker is estimated to increase accordingly, e.g. for advanced disease at diagnosis, from 3983 to 5448 for dMMR, from 2484 to 3553 for MSI, and from 13,310 to 17,893 for high TMB (representing 3·6%, 2·3% and 11·8% of 5-year prevalence of individuals with advanced disease at diagnosis, respectively; noting considerable overlap in the presence of these biomarkers).

Interpretation

We present the first long-term projections for cancer prevalence associated with key pan-tumour biomarkers in Australia, to inform health policy and healthcare planning for targeted therapies.

Funding

Medical Research Future Fund—Preventive and Public Health Research Initiative—2019 Targeted Health System and Community Organization Research Grant Opportunity (MRF1200535), Cancer Institute NSW Career Development Fellowship (2022/CDF1154), National Health and Medical Research Council of Australia Investigator Grant (APP1194679).
{"title":"Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042","authors":"Yoon-Jung Kang ,&nbsp;Qingwei Luo ,&nbsp;Joachim Worthington ,&nbsp;Anna Kelly ,&nbsp;Jeff Cuff ,&nbsp;John Zalcberg ,&nbsp;Karen Canfell ,&nbsp;Julia Steinberg","doi":"10.1016/j.lanwpc.2025.101537","DOIUrl":"10.1016/j.lanwpc.2025.101537","url":null,"abstract":"<div><h3>Background</h3><div>Targeted cancer treatment based on mismatch repair deficiency (dMMR), microsatellite instability (MSI), or high tumour mutational burden (TMB) holds promise for improving patient outcomes, but presents substantial healthcare costs.</div></div><div><h3>Methods</h3><div>Using validated statistical methods, we projected 1-year to 5-year prevalence of individuals diagnosed with solid tumours exhibiting these biomarkers in Australia to 2042, for all solid cancers combined and 23 individual cancer types/groups, and separately for all stages combined, advanced disease at diagnosis (here, distant metastasis/lymph node involvement), and advanced disease after progression post-diagnosis.</div></div><div><h3>Findings</h3><div>The 5-year prevalence of individuals diagnosed with any solid cancer regardless of biomarker status is estimated to increase by 54·2%, from 438,346 in 2018 to 675,722 in 2042 (advanced disease at diagnosis: by 37·6% from 109,855 to 151,199), primarily due to population growth and ageing. The 5-year prevalence of individuals whose tumours exhibit a biomarker is estimated to increase accordingly, e.g. for advanced disease at diagnosis, from 3983 to 5448 for dMMR, from 2484 to 3553 for MSI, and from 13,310 to 17,893 for high TMB (representing 3·6%, 2·3% and 11·8% of 5-year prevalence of individuals with advanced disease at diagnosis, respectively; noting considerable overlap in the presence of these biomarkers).</div></div><div><h3>Interpretation</h3><div>We present the first long-term projections for cancer prevalence associated with key pan-tumour biomarkers in Australia, to inform health policy and healthcare planning for targeted therapies.</div></div><div><h3>Funding</h3><div>Medical Research Future Fund—Preventive and Public Health Research Initiative—2019 <span>Targeted Health System</span> and <span>Community Organization Research</span> Grant Opportunity (MRF1200535), <span>Cancer Institute NSW</span> Career Development Fellowship (2022/CDF1154), <span>National Health and Medical Research Council of Australia</span> Investigator Grant (APP1194679).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"57 ","pages":"Article 101537"},"PeriodicalIF":7.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143769096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Area-level socioeconomic inequalities in hypertension care cascade in China: a nationwide population-based study based on the ChinaHEART project
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-01 DOI: 10.1016/j.lanwpc.2025.101544
Wenyao Peng , Siqi Lin , Xuan Liu , Bowang Chen , Xueke Bai , Chaoqun Wu , Xiaoyan Zhang , Yang Yang , Jianlan Cui , Wei Xu , Lijuan Song , Hao Yang , Wenyan He , Yan Zhang , Xi Li , Jiapeng Lu

Background

Socioeconomic status (SES) is one of key social determinants of health. Compared to individual-level SES, the association between area-level SES and hypertension management has been understudied and under-recognised. In this study, we aimed to assess the association between area-level SES and hypertension awareness, treatment, combination therapy and control, and the modification effect of individual characteristics on the associations.

Methods

During Dec 2015 and Dec 2022, 1,559,748 residents with hypertension aged 35–75 years from 31 provinces in the China Health Evaluation And risk Reduction through nationwide Teamwork (ChinaHEART) were included. The composite value of area-level SES was generated from national census data and categorized into tertiles. Multivariable mixed models with random effects to account for county-level administrative area were fitted to compute odds ratios (OR) and 95% confidence intervals (CIs) for the independent and interactive associations of both area- and individual-level SES with hypertension management (awareness, treatment, combination therapy and control) and their disparities across different population subgroups.

Findings

Among the included participants with hypertension aged 59·1 ± 9·1 years, 794,675 (50·95%), 650,485 (41·70%) and 206,103 (13·21%) were aware, treated, and controlled, respectively. Compared with the high area-level SES group, the low group was significantly associated with a lower odds of hypertension awareness (OR: 0·75, 95% CI: 0·65–0·86), treatment (0·69, 0·59–0·81), combination therapy (0·65, 0·51–0·84), and control (0·62, 0·51–0·75). Participants with low SES at both individual and area level had the lowest odds of hypertension management. Area-level SES had stronger influences on hypertension awareness, treatment and control, but a weaker influence on combination therapy, in the young and those with high individual-level SES.

Interpretation

Area-level SES on plays a key role in the awareness, treatment, combination therapy and control of hypertension, with different magnitude of associations. Integrated action to improve area-level circumstances and promote targeted interventions to hypertension care cascade are needed to reduce health inequalities in China.

Funding

The CAMS Innovation Fund for Medical Science; the National High Level Hospital Clinical Research Funding; the National Natural Science Foundation of China of China; the Ministry of Finance of China and National Health Commission of China; the 111 Project from the Ministry of Education of China.
{"title":"Area-level socioeconomic inequalities in hypertension care cascade in China: a nationwide population-based study based on the ChinaHEART project","authors":"Wenyao Peng ,&nbsp;Siqi Lin ,&nbsp;Xuan Liu ,&nbsp;Bowang Chen ,&nbsp;Xueke Bai ,&nbsp;Chaoqun Wu ,&nbsp;Xiaoyan Zhang ,&nbsp;Yang Yang ,&nbsp;Jianlan Cui ,&nbsp;Wei Xu ,&nbsp;Lijuan Song ,&nbsp;Hao Yang ,&nbsp;Wenyan He ,&nbsp;Yan Zhang ,&nbsp;Xi Li ,&nbsp;Jiapeng Lu","doi":"10.1016/j.lanwpc.2025.101544","DOIUrl":"10.1016/j.lanwpc.2025.101544","url":null,"abstract":"<div><h3>Background</h3><div>Socioeconomic status (SES) is one of key social determinants of health. Compared to individual-level SES, the association between area-level SES and hypertension management has been understudied and under-recognised. In this study, we aimed to assess the association between area-level SES and hypertension awareness, treatment, combination therapy and control, and the modification effect of individual characteristics on the associations.</div></div><div><h3>Methods</h3><div>During Dec 2015 and Dec 2022, 1,559,748 residents with hypertension aged 35–75 years from 31 provinces in the China Health Evaluation And risk Reduction through nationwide Teamwork (ChinaHEART) were included. The composite value of area-level SES was generated from national census data and categorized into tertiles. Multivariable mixed models with random effects to account for county-level administrative area were fitted to compute odds ratios (OR) and 95% confidence intervals (CIs) for the independent and interactive associations of both area- and individual-level SES with hypertension management (awareness, treatment, combination therapy and control) and their disparities across different population subgroups.</div></div><div><h3>Findings</h3><div>Among the included participants with hypertension aged 59·1 ± 9·1 years, 794,675 (50·95%), 650,485 (41·70%) and 206,103 (13·21%) were aware, treated, and controlled, respectively. Compared with the high area-level SES group, the low group was significantly associated with a lower odds of hypertension awareness (OR: 0·75, 95% CI: 0·65–0·86), treatment (0·69, 0·59–0·81), combination therapy (0·65, 0·51–0·84), and control (0·62, 0·51–0·75). Participants with low SES at both individual and area level had the lowest odds of hypertension management. Area-level SES had stronger influences on hypertension awareness, treatment and control, but a weaker influence on combination therapy, in the young and those with high individual-level SES.</div></div><div><h3>Interpretation</h3><div>Area-level SES on plays a key role in the awareness, treatment, combination therapy and control of hypertension, with different magnitude of associations. Integrated action to improve area-level circumstances and promote targeted interventions to hypertension care cascade are needed to reduce health inequalities in China.</div></div><div><h3>Funding</h3><div>The <span>CAMS Innovation Fund</span> for Medical Science; the <span>National High Level Hospital Clinical Research Funding</span>; the <span>National Natural Science Foundation of China</span> of China; the <span>Ministry of Finance</span> of China and <span>National Health Commission</span> of China; the 111 Project from the <span>Ministry of Education of China</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"57 ","pages":"Article 101544"},"PeriodicalIF":7.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143776279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping residual malaria transmission in Vietnam
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-04-01 DOI: 10.1016/j.lanwpc.2025.101545
Michael A. McPhail , Yalemzewod Assefa Gelaw , Xuan Thang Nguyen , Win Han Oo , Freya J.I. Fowkes , Duc Thang Ngo , Thi Hong Phuc Nguyen , Tasmin L. Symons , Dan J. Weiss , Peter W. Gething

Background

Vietnam, as one of the countries in the Greater Mekong Subregion, has committed to eliminating all malaria by 2030. Declining case numbers highlight the country's progress, but challenges including imported cases and pockets of residual transmission remain. To successfully eliminate malaria and to prevent reintroduction of malaria transmission, geostatistical modelling of vulnerability (importation rate) and receptivity (quantified by the reproduction number) of malaria is critical.

Methods

Case data from 2019 to 2022 was used to train a range of network and geostatistical models, from which strategically useful metrics were computed. These metrics include vulnerability, which was estimated from the abundance of imported cases, and receptivity, which was estimated based on a transmission model linking cases as well as environmental covariate data.

Findings

There is considerable spatiotemporal heterogeneity in the computed metrics. Importations are concentrated in the South Central Coast and Central highlands regions. The importation rate of Plasmodium falciparum is around 2.5 times higher than that of P. vivax. The mean computed reproduction number is less than one, which is consistent with the historical decline in cases and eventual elimination. There are, however, places where the estimated reproduction number can temporarily exceed one, which explains the seasonal case resurgence observed in the case data. The reproduction number is typically higher in forested areas.

Interpretation

Receptivity and vulnerability to malaria is spatiotemporally heterogeneous in Vietnam. Despite the average reproduction number being less than one, the spatial pockets and temporal windows of elevated reproduction number could prevent timely elimination of malaria or even lead to a reversal of progress. The predictive maps presented in this paper can inform appropriate intervention strategies to advance goals of malaria elimination.

Funding

This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV-055192 and INV-009390/OPP1197730]. The conclusions and opinions expressed in this work are those of the author(s) alone and shall not be attributed to the Foundation. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. Please note works submitted as a preprint have not undergone a peer review process. This work also includes funding support from the Australian Government, National Health and Medical Research Council (Award No: GNT2025280) and Telethon Trust, Western Australia.
{"title":"Mapping residual malaria transmission in Vietnam","authors":"Michael A. McPhail ,&nbsp;Yalemzewod Assefa Gelaw ,&nbsp;Xuan Thang Nguyen ,&nbsp;Win Han Oo ,&nbsp;Freya J.I. Fowkes ,&nbsp;Duc Thang Ngo ,&nbsp;Thi Hong Phuc Nguyen ,&nbsp;Tasmin L. Symons ,&nbsp;Dan J. Weiss ,&nbsp;Peter W. Gething","doi":"10.1016/j.lanwpc.2025.101545","DOIUrl":"10.1016/j.lanwpc.2025.101545","url":null,"abstract":"<div><h3>Background</h3><div>Vietnam, as one of the countries in the Greater Mekong Subregion, has committed to eliminating all malaria by 2030. Declining case numbers highlight the country's progress, but challenges including imported cases and pockets of residual transmission remain. To successfully eliminate malaria and to prevent reintroduction of malaria transmission, geostatistical modelling of vulnerability (importation rate) and receptivity (quantified by the reproduction number) of malaria is critical.</div></div><div><h3>Methods</h3><div>Case data from 2019 to 2022 was used to train a range of network and geostatistical models, from which strategically useful metrics were computed. These metrics include vulnerability, which was estimated from the abundance of imported cases, and receptivity, which was estimated based on a transmission model linking cases as well as environmental covariate data.</div></div><div><h3>Findings</h3><div>There is considerable spatiotemporal heterogeneity in the computed metrics. Importations are concentrated in the South Central Coast and Central highlands regions. The importation rate of <em>Plasmodium falciparum</em> is around 2.5 times higher than that of <em>P. vivax.</em> The mean computed reproduction number is less than one, which is consistent with the historical decline in cases and eventual elimination. There are, however, places where the estimated reproduction number can temporarily exceed one, which explains the seasonal case resurgence observed in the case data. The reproduction number is typically higher in forested areas.</div></div><div><h3>Interpretation</h3><div>Receptivity and vulnerability to malaria is spatiotemporally heterogeneous in Vietnam. Despite the average reproduction number being less than one, the spatial pockets and temporal windows of elevated reproduction number could prevent timely elimination of malaria or even lead to a reversal of progress. The predictive maps presented in this paper can inform appropriate intervention strategies to advance goals of malaria elimination.</div></div><div><h3>Funding</h3><div>This work was supported, in whole or in part, by the <span>Bill &amp; Melinda Gates Foundation</span> [INV-055192 and INV-009390/OPP1197730]. The conclusions and opinions expressed in this work are those of the author(s) alone and shall not be attributed to the Foundation. Under the grant conditions of the Foundation, a <span>Creative Commons</span> Attribution 4.0 License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. Please note works submitted as a preprint have not undergone a peer review process. This work also includes funding support from the <span>Australian Government</span>, <span>National Health and Medical Research Council</span> (Award No: GNT2025280) and <span>Telethon Trust</span>, Western Australia.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"57 ","pages":"Article 101545"},"PeriodicalIF":7.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet Regional Health: Western Pacific
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1